This study introduces a scalable chromatin imaging assay to identify immune cell alterations associated with type 2 diabetes progression, supporting personalized disease monitoring and management.
Categories:
Scientific Paper
This study introduces a scalable chromatin imaging assay to identify immune cell alterations associated with type 2 diabetes progression, supporting personalized disease monitoring and management.
Follow us on social media to benefit
from a range of useful resources.
Disclaimer: Translations were created with the help of AI. Heidelberg Instruments does not guarantee the correctness of the translations.